A Prospective Observational Study to Elucidate the Mechanism of Gastrointestinal Mucosal Damage and Thrombosis in Patients with COVID-19

A Prospective Observational Study to Elucidate the Mechanism of Gastrointestinal Mucosal Damage and Thrombosis in Patients with COVID-19 - A Study to Elucidate the Gastrointestinal mucosal damage in Patients with COVID-19

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046106

Enrollment

100

Registered

2021-11-22

Start date

2021-09-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Male and female, ages 18 or older 2) Be willing to provide informed consent 3) SARS-CoV-2 nucleic acid detection by Real-Time PCR or SARS-CoV-2 antigen by a rapid diagnostic assay in the samples from the nasopharyngeal or oropharyngeal swab, or salvia.

Exclusion criteria

Exclusion criteria: 1) Unconfirmed diagnosis for SARS-CoV-2 2) Rejection or Withdrawn of informed consent 3) Patients judged by the principal investigator to be ineligible.

Design outcomes

Primary

Measure	Time frame
The severity of COVID-19 and changes in gut microbiota or metabolites	—

Countries

Japan

Contacts

Public ContactYoshihiro Yokoyama

Sapporo medical university Department of gastroenterology and hepatology

yoshi_yokoyamaa@yahoo.co.jp0116112111

Outcome results